Crohn’s Disease Treatment: Biologics, Risankizumab, Ustekinumab, Anti-TNF Failure and Remission

Review Risankizumab vs Ustekinumab in Crohn’s Disease with a focused overview of Crohn disease treatment, risankizumab, and ustekinumab. It also examines anti-TNF failure, biologic therapy, and clinical remission, with context on symptom patterns, diagnostic testing, endoscopy findings, medication choices, diet, and follow-up. People searching for Crohn disease treatment, anti-TNF failure, or biologic therapy can use this video to understand how gastroenterologists approach digestive symptoms, inflammation, bleeding, malabsorption, or chronic liver and pancreatic disease. Useful for connecting common GI symptoms with the tests and treatments used in modern gastroenterology. Gastroenterology care often combines diet medication endoscopic therapy surveillance and long-term disease